Moreover, PTEN-loss senescent cells secrete immunosuppressive chemokines through the activation of janus-activated kinase 2/signal transducer and activator of transcription 3, leading to an immunosuppressive TME in prostate cancer [57]. This evidence concerns the gene PTEN and prostate cancer.